DPHARMA-7148

DUOPHARMA BIOTECH BERHAD

Last Price: 1.25

TTM Dividend Yield : 2.01%

Coming Quarter Report: ~ 2025-02-22

Yahoo Google Bursa Web TradingView

Sector: Pharmaceuticals

No record found

**Do feedback to us if you see any error on the data

**Data before 2015 may not be accurate

**Dividend Yield calculated base on the last price of the year

DPHARMA Dividend Yield Trend

DPHARMA Quarter DY Yield

Year	Financial Year	DY_Type	Announced	EX Date	Payment Date	DY($)	Yield%
2024	31/12/2024	First Interim	15/08/2024	29/08/2024	12/09/2024	0.01	0.85
2023	31/12/2023	Second Interim	22/02/2024	07/03/2024	21/03/2024	0.018	1.54
2023	31/12/2023	First Interim	24/08/2023	08/09/2023	22/09/2023	0.005	0.43
2022	31/12/2022	Second Interim	27/03/2023	07/04/2023	09/05/2023	0.018	1.54
2022	31/12/2022	First Interim	16/08/2022	29/08/2022	14/09/2022	0.005	0.43
2021	31/12/2021	Second Interim	24/03/2022	14/04/2022	13/05/2022	0.018	1.54
2021	31/12/2021	First Interim	17/08/2021	30/08/2021	15/09/2021	0.005	0.43
2020	31/12/2020	Second Interim	08/04/2021	21/04/2021	21/05/2021	0.06	5.13
2020	31/12/2020	Interim	13/08/2020	28/08/2020	11/09/2020	0.005	0.43
2019	31/12/2019	Final	30/06/2020	13/07/2020	12/08/2020	0.05	4.27
2019	31/12/2019	Interim	02/10/2019	15/10/2019	14/11/2019	0.01	0.85
2018	31/12/2018	Final	13/06/2019	26/06/2019	26/07/2019	0.04	3.42
2018	31/12/2018	First Interim	22/10/2018	02/11/2018	23/11/2018	0.015	1.28
2017	31/12/2017	Final	31/05/2018	13/06/2018	17/07/2018	0.06	5.13
2017	31/12/2017	Interim	25/08/2017	17/10/2017	10/11/2017	0.025	2.14
2016	31/12/2016	Final	24/02/2017	26/05/2017	23/06/2017	0.04	3.42
2016	31/12/2016	Interim	22/08/2016	19/10/2016	11/11/2016	0.025	2.14
2015	31/12/2015	Final	23/02/2016	06/06/2016	28/06/2016	0.055	4.70
2015	31/12/2015	Interim	25/08/2015	13/10/2015	06/11/2015	0.04	3.42
2014	31/12/2014	Final	24/02/2015	27/05/2015	25/06/2015	0.145	12.39
2014	31/12/2014	Interim	26/08/2014	15/10/2014	07/11/2014	0.04	3.42
2013	31/12/2013	Interim	28/08/2013	14/10/2013	08/11/2013	0.04	3.42
2012	31/12/2012	Final	22/03/2013	14/06/2013	12/07/2013	0.105	8.97
2012	31/12/2012	Interim	16/08/2012	15/10/2012	09/11/2012	0.035	2.99
2011	31/12/2011	Final	16/03/2012	06/06/2012	29/06/2012	0.145	12.39
2011	31/12/2011	Interim	18/08/2011	05/10/2011	28/10/2011	0.035	2.99
2010	31/12/2010	Final	21/04/2011	08/06/2011	27/06/2011	0.11	9.40
2010	31/12/2010	Interim	02/09/2010	06/10/2010	28/10/2010	0.045	3.85
2009	31/12/2009	Final	21/04/2010	09/06/2010	25/06/2010	0.12	10.26
2009	31/12/2009	Interim	26/08/2009	01/10/2009	23/10/2009	0.06	5.13
		Final	26/02/2014	22/05/2014	20/06/2014	0.135	11.54
2008	31/12/2008	Interim	26/08/2008	08/10/2008	28/10/2008	0.16	13.68
2007	31/12/2007	Interim	28/11/2007	10/12/2007	24/12/2007	0.68	58.12
2007	31/12/2007	Interim	24/08/2007	03/10/2007	18/10/2007	0.28	23.93
2006	31/12/2006	Final	25/04/2007	29/05/2007	08/06/2007	0.29	24.79
2006	31/12/2006	Interim	23/08/2006	11/09/2006	22/09/2006	0.14	11.97
2005	31/12/2005	First & Final	24/04/2006	18/05/2006	08/06/2006	0.35	29.91
2004	31/12/2004	Final	06/06/2005	26/07/2005	18/08/2005	0.12	10.26
2004	31/12/2004	Interim	06/10/2004	21/10/2004	08/11/2004	0.06	5.13
2003	31/12/2003	Final	01/06/2004	06/07/2004	28/07/2004	0.08	6.84
2003	31/12/2003	Interim	09/09/2003	26/09/2003	20/10/2003	0.05	4.27
2002	31/12/2002	First & Final	25/04/2003	23/06/2003	08/07/2003	0.08	6.84

DPHARMA Annual DY Yield

Year	Annual DY($)	Frequency per yr	SpecialDY	Yield%
2024	0.01	1	No	0.85
2023	0.023	2	No	1.97
2022	0.023	2	No	1.97
2021	0.023	2	No	1.97
2020	0.065	2	No	5.56
2019	0.06	2	No	5.13
2018	0.055	2	No	4.70
2017	0.085	2	No	7.26
2016	0.065	2	No	5.56
2015	0.095	2	No	8.12
2014	0.185	2	No	15.81
2013	0.04	1	No	3.42
2012	0.14	2	No	11.97
2011	0.18	2	No	15.38
2010	0.155	2	No	13.25
2009	0.18	2	No	15.38
2008	0.16	1	No	13.68
2007	0.96	2	No	82.05
2006	0.43	2	No	36.75
2005	0.35	1	No	29.91
2004	0.18	2	No	15.38
2003	0.13	2	No	11.11
2002	0.08	1	No	6.84

DPHARMA Quarter Report History

Q Date	Announced	Revenue	P/L	EPS	Margin	QoQ%	YoY%
30/09/2024	08/11/2024	208,700,000	15,600,000.00	1.62	7.47	-6.59	73.33
30/06/2024	15/08/2024	218,300,000	16,700,000.00	1.73	7.65	9.15	33.60
31/03/2024	23/05/2024	193,000,000	15,300,000.00	1.59	7.93	80.00	-32.30
31/12/2023	22/02/2024	167,500,000	8,500,000.00	0.88	5.07	-5.56	-50.58
30/09/2023	08/11/2023	169,200,000	9,000,000.00	0.93	5.32	-28.00	-44.79
30/06/2023	24/08/2023	167,500,000	12,500,000.00	1.31	7.46	-44.69	-23.31
31/03/2023	22/05/2023	200,500,000	22,600,000.00	2.38	11.27	31.40	11.33
31/12/2022	23/02/2023	152,000,000	17,200,000.00	1.80	11.32	5.52	9.55
30/09/2022	09/11/2022	177,100,000	16,300,000.00	1.72	9.20	0.00	-4.12
30/06/2022	16/08/2022	181,700,000	16,300,000.00	1.72	8.97	-19.70	5.84

DPHARMA Quarter Profit Trend

DPHARMA Annual Profit Trend

Cash Flow

In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long – term investment on capital items or investment in securities.(From Wiki)

DPHARMA Annual Cash Flow

ROE & Payout Ratio

Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)

The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)

DPHARMA Annual ROE & Payout Ratio

0 Comments

VictorFoo November 26, 2020 at 4:25 pm

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Dividends.my

Malaysia Dividends Ranking Website